Gayle has more than 20 years of experience, in biomarker and omics research.
Leading a large, multi-skilled translational science laboratory team, within a global Pharma department supporting biomarker strategies across 14 drug discovery programs covering more than 20 clinical studies, through to leading a large multi-disciplinary team within MDC. Gayle directs multi-biomarker analysis and assay development, supporting diagnostic development initiatives, and delivering key pre-clinical and clinical biomarker data.
Gayle is currently working at Medicines Discovery Catapult as Head of Biomarkers, supporting SMEs, academics and drug discovery researchers to identify the right biomarkers and clinical approach for their drug or asset development.
